Gastric neuroendocrine neoplasms
G Lamberti, F Panzuto, M Pavel, D O'Toole… - Nature Reviews …, 2024 - nature.com
Gastric neuroendocrine neoplasms (gNENs) display peculiar site-specific features among
all NENs. Their incidence and prevalence have been rising in the past few decades. gNENs …
all NENs. Their incidence and prevalence have been rising in the past few decades. gNENs …
Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent …
M Passhak, MG McNamara, RA Hubner… - Best Practice & …, 2023 - Elsevier
Gastro-enterohepatic neuroendocrine tumours (GEP-NETs) represent a rare and highly
heterogeneous entity with increasing incidence. Based on the results obtained from several …
heterogeneous entity with increasing incidence. Based on the results obtained from several …
Polymer composite microspheres loading 177Lu radionuclide for interventional radioembolization therapy and real-time SPECT imaging of hepatic cancer
L Xiao, Y Li, R Geng, L Chen, P Yang, M Li… - Biomaterials …, 2023 - spj.science.org
Background Transarterial radioembolization (TARE) with 90Y-labeled glass and resin
microspheres is one of the primary treatment strategies for advanced-stage primary and …
microspheres is one of the primary treatment strategies for advanced-stage primary and …
Development of Alginate-Based Biodegradable Radioactive Microspheres Labeled with Positron Emitter through Click Chemistry Reaction: Stability and PET Imaging …
Biodegradable radioactive microspheres labeled with positron emitters hold significant
promise for diagnostic and therapeutic applications in cancers and other diseases, including …
promise for diagnostic and therapeutic applications in cancers and other diseases, including …
Radionuclide theranostics in neuroendocrine neoplasms: an update
M Di Franco, L Zanoni, E Fortunati, S Fanti… - Current Oncology …, 2024 - Springer
Abstract Purpose of Review This paper aims to address the latest findings in
neuroendocrine tumor (NET) theranostics, focusing on new evidence and future directions of …
neuroendocrine tumor (NET) theranostics, focusing on new evidence and future directions of …
Use and perceived utility of [18F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) …
V Ambrosini, M Caplin, JP Castaño… - Journal of …, 2024 - Wiley Online Library
Abstract Somatostatin receptor (SST) PET/CT is the gold standard for well‐differentiated
neuroendocrine tumours (NET) imaging. Higher grades of neuroendocrine neoplasms …
neuroendocrine tumours (NET) imaging. Higher grades of neuroendocrine neoplasms …
Comparison of 68Ga-DOTANOC and 18F-FDOPA PET/CT for Detection of Recurrent or Metastatic Paragangliomas
L Bian, J Xu, P Li, L Bai, S Song - Radiology: Imaging Cancer, 2024 - pubs.rsna.org
Purpose To evaluate the diagnostic performance of gallium 68 (68Ga)-DOTA-NaI3-
octreotide (68Ga-DOTANOC) and fluorine 18 (18F)-fluoro-l-3, 4-dihydroxyphenylalanine …
octreotide (68Ga-DOTANOC) and fluorine 18 (18F)-fluoro-l-3, 4-dihydroxyphenylalanine …
[HTML][HTML] Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)
Rationale: Peptide receptor radionuclide therapy (PRRT) for the treatment of
neuroendocrine tumors (NETs) has been explored for more than two decades, but there are …
neuroendocrine tumors (NETs) has been explored for more than two decades, but there are …
Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety
P Malandrino, T Feola, N Mikovic, G Cannavale… - Seminars in Nuclear …, 2024 - Elsevier
Neuroendocrine neoplasms (NENs), arising from various sites, present therapeutic
challenges. Radioligand therapy (RLT) is effective for unresectable/metastatic NENs with …
challenges. Radioligand therapy (RLT) is effective for unresectable/metastatic NENs with …
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy
R Gujarathi, S Abou Azar, J Tobias… - Endocrine-Related …, 2024 - erc.bioscientifica.com
Pre-clinical data suggest that mutations in the MEN1, DAXX, and/or ATRX genes may
potentially increase radiation efficacy in cancer cells. Herein, we explore the association …
potentially increase radiation efficacy in cancer cells. Herein, we explore the association …